EDITORIAL
Published on 18 Oct 2022
Editorial: Gastrointestinal cancer immune response and immune related adverse effects
doi 10.3389/fonc.2022.1034890
- 556 views
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Gastrointestinal Cancer Immune Response and Immune Related Adverse Effects
Gastrointestinal Cancer Immune Response and Immune Related Adverse Effects
49k
Total downloads
110k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 08 Aug 2022
PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis
doi 10.3389/fimmu.2022.905651
- 3,983 views
- 10 citations
ORIGINAL RESEARCH
Published on 02 Jun 2022
Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)
doi 10.3389/fimmu.2022.849984
- 3,469 views
- 38 citations
ORIGINAL RESEARCH
Published on 24 Jan 2022
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer
doi 10.3389/fimmu.2021.758040
- 9,006 views
- 37 citations
ORIGINAL RESEARCH
Published on 18 Jan 2022
Safety and Efficacy of Camrelizumab in Combination With Nab-Paclitaxel Plus S-1 for the Treatment of Gastric Cancer With Serosal Invasion
doi 10.3389/fimmu.2021.783243
- 2,403 views
- 22 citations
CASE REPORT
Published on 13 Jan 2022
Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer
doi 10.3389/fonc.2021.759652
- 1,620 views
- 5 citations
REVIEW
Published on 07 Jan 2022
Potential Role of the Gut Microbiome In Colorectal Cancer Progression
doi 10.3389/fimmu.2021.807648
- 28,135 views
- 122 citations
CASE REPORT
Published on 06 Jan 2022
Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient
doi 10.3389/fimmu.2021.784861
- 3,174 views
- 6 citations
ORIGINAL RESEARCH
Published on 24 Nov 2021
Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
doi 10.3389/fimmu.2021.723293
- 3,358 views
- 5 citations
REVIEW
Published on 29 Oct 2021
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
doi 10.3389/fimmu.2021.768957
- 8,273 views
- 31 citations
ORIGINAL RESEARCH
Published on 30 Sep 2021
Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for Colorectal Cancer
doi 10.3389/fimmu.2021.760747
- 2,342 views
- 16 citations
ORIGINAL RESEARCH
Published on 17 Sep 2021
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
doi 10.3389/fimmu.2021.719175
- 22,067 views
- 152 citations
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore